{"id":59,"date":"2022-11-28T20:52:54","date_gmt":"2022-11-28T20:52:54","guid":{"rendered":"https:\/\/voxzogohcp-dev-001.azurewebsites.net\/en-us\/voxzogo\/?page_id=59"},"modified":"2024-11-14T01:16:15","modified_gmt":"2024-11-14T01:16:15","slug":"understanding-achondroplasia","status":"publish","type":"page","link":"https:\/\/www.voxzogo.com\/en-us\/understanding-achondroplasia\/","title":{"rendered":"Understanding achondroplasia"},"content":{"rendered":"
Annika, 14, on VOXZOGO since 9 years old as part of a clinical trial<\/p>\n\t\t\t\t <\/div>\n\t\t\t\t <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n
Most bones start to grow before birth and continue for as long as bones growth plates<\/span> stay open. As long as children’s growth plates remain open, there is an opportunity for growth.<\/p>\n <\/div>\n\n A balance between fibroblast growth factor receptor 3 (FGFR3<\/span>) and C-type natriuretic peptide (CNP<\/span>) signaling pathways occurs within the cells in the growth plate. In achondroplasia<\/span>, FGFR3 sends more signals to slow bone growth than it should. VOXZOGO increases CNP signaling, alongside the body’s natural CNP, to improve bone growth.<\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
<\/div>\n <\/figure>\n <\/div>\n <\/div>\n<\/div>\n\nVOXZOGO works alongside the body’s natural CNP to increase signaling and improve the balance.<\/h2>\n
By increasing CNP signaling, VOXZOGO®<\/sup> (vosoritide) increases the rate of bone growth.<\/h2>\n <\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n
Find out how VOXZOGO works alongside the body’s natural CNP to increase growth signals.<\/h3>\n